Aligos Therapeutics, Inc. Common Stock

ALGSNASDAQ • USD
1.83 USD
↘ 0.27 (12.90%)🟢LIVE (AS OF 09:40 AM EST)
🟢Market: OPEN

ALGS is currently priced at $1.83. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$2.11
High?$2.15
Low?$1.83
Prev. Close?$2.10
Volume?13.1K
Avg. Volume?55.7K
VWAP?$1.96
Rel. Volume?0.23x
Bid / Ask
Bid?$1.67 × 100
Ask?$2.64 × 100
Spread?$0.97
Midpoint?$2.16
Valuation & Ratios
Market Cap?13.1M
Shares Out?6.2M
Float?5.6M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?1.16
EPS?-$10.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Employees
82
Market Cap
13.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-10-16
Address
ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
50
Short Sent.?
48
Piotroski F-Score?4/9Mixed
Altman Z-Score?-24.19Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?12.15%High
Short Interest?677.2K
Days to Cover?20.8
Free Float5.6M
Avg Daily Volume32.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.77Adequate
Quick Ratio?1.77Adequate
Cash Ratio?1.59Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
94
1.16CHEAP▾
P/S?
Peers
100
S&P
97
0.39CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.3CHEAP▾
EV/Sales?
S&P
97
-0.53CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-586.3%WEAK▾
ROA?
S&P
3
-140.5%WEAK▾
Cash Flow & Enterprise
FCF?$-68661000
Enterprise Value?$-17913196
Fundamentals ratios updated end of day